Company: PCRX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001396814-25-000061
Chunk: 155

Company: Pacira BioSciences, Inc.
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 8
Chunk 155
---
 an employee or member of the board of directors or the board of directors of any parent or subsidiary, or following a bona fide period of non-employment by the Company or a parent or subsidiary, if he or she is granted such award in connection with his or her commencement of employment with the Company or a subsidiary and such grant is an inducement material to his or her entering into employment with the Company or such subsidiary.Inducement AwardsFrom time to time, the board of directors, upon recommendation of the P&C Committee, has approved individually negotiated grants of options and restricted stock units for certain of the Company’s officers in connection with their respective appointments, in each case, pursuant to the inducement plan in effect at such time.Stock-Based CompensationThe Company recognized stock-based compensation expense in the periods presented as follows (in thousands):Three Months EndedMarch 31,20252024Cost of goods sold$1,716 $1,128 Research and development2,241 1,803 Selling, general and administrative10,596 7,985 Contingent consideration gains, acquisition-related expenses, restructuring and other— 2,235         Total$14,553 $13,151 Stock-based compensation from:    Stock options$4,440 $6,729     Restricted stock units9,606 6,210     Employee stock purchase plan share options507 212         Total$14,553 $13,151 

Pacira BioSciences, Inc.  |  Q1 2025 Form 10-Q  |  Page 26

Equity AwardsThe following tables contain information about the Company’s stock option and restricted stock unit, or RSU, activity for the three months ended March 31, 2025:Stock Options Number ofStock Options Weighted Average Exercise Price (Per Share) Outstanding at December 31, 20246,845,618 $42.95      Granted252,300 25.65      Forfeited(10,485)29.08      Expired(253,556)45.57  Outstanding at March 31, 20256,833,877 42.23 Restricted Stock Units Number ofRestrictedStock Units Weighted Average Grant Date Fair Value (Per Share)Unvested at December 31, 20242,769,728 $32.07      Granted2,